Enoxaparin sodium and Pitavastatin calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Enoxaparin sodium (enoxaparin sodium) and Pitavastatin calcium (pitavastatin calcium). Common drug interactions include lung infection among females and recurrence of neuromuscular blockade among males.

The phase IV clinical study analyzes what interactions people have when they take Enoxaparin sodium and Pitavastatin calcium. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Enoxaparin sodium?

Enoxaparin sodium has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 24,181 Enoxaparin sodium users. Check the latest studies of Enoxaparin sodium.

What is Pitavastatin calcium?

Pitavastatin calcium has active ingredients of pitavastatin calcium. eHealthMe is studying from 1,710 Pitavastatin calcium users. Check the latest studies of Pitavastatin calcium.

On Jul, 06, 2026

12 people who take Enoxaparin sodium and Pitavastatin calcium together, and have interactions are studied.

Enoxaparin sodium and Pitavastatin calcium drug interactions.

What are the common drug interactions of Enoxaparin Sodium and Pitavastatin Calcium, by gender? *:

female:

Lung infection
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Chest discomfort
Herpes zoster
Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
Cardiac failure acute
Liver injury

male:

Recurrence of neuromuscular blockade (repeat neuromuscular block)
Respiratory failure (inadequate gas exchange by the respiratory system)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Therapeutic response decreased (less preventive response)
Coagulation time prolonged

What are the common drug interactions of Enoxaparin Sodium and Pitavastatin Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Lung infection
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Cardiac failure acute

60+:

Recurrence of neuromuscular blockade (repeat neuromuscular block)
Respiratory failure (inadequate gas exchange by the respiratory system)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Chest discomfort
Herpes zoster
Post herpetic neuralgia (neuralgia caused by the varicella zoster virus)
Therapeutic response decreased (less preventive response)
Coagulation time prolonged
Liver injury

What are the existing conditions these people have? *

Neuromuscular Blockade Reversal: 4 people, 33.33%
Neuromuscular Blockade: 4 people, 33.33%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 3 people, 25.00%
Pneumonia: 2 people, 16.67%
Urticaria Chronic (long lasting rash of round, red welts on the skin that itch intensely): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Cerebral Arteriosclerosis (thickening and hardening of the walls of the arteries in the brain): 1 person, 8.33%
Constipation: 1 person, 8.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 8.33%
Dehydration (dryness resulting from the removal of water): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Enoxaparin sodium and Pitavastatin calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously